In this issue:
Predicting the future diabetes burden in Australia
Aliskiren and CV complications/pancreatic injury in mice
Aspirin vs. placebo in diabetes for primary CV event prevention
Aspirin in primary CV event prevention: diabetics vs. nondiabetics
RealTrend: an in
Please login below to download this issue (PDF)